Ledger.Open graph →
SEC Form D · filed September 23, 2025

Volastra Therapeutics, Inc

Offering
$30.1M
Sold
$30.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Sandra Peterson · NEW YORK, NYDirectorRobert Mittendorff · Miami, FLDirectorSamuel Bakhoum · NEW YORK, NYDirectorJill Goldstein · NEW YORK, NYDirectorDavid Southwell · Boston, MAExec · DirectorArjun Balar · NEW YORK, NYDirectorEllie Mcguire · Cambridge, MADirectorLuc Dochez · Leiden, P7DirectorDavid Nicholson · New York, NYDirectorSandra Peterson · NEW YORK, NYDirectorRobert Mittendorff · Sunnyvale, CADirectorJill Goldstein · NEW YORK, NYDirectorDavid Southwell · Waltham, MAExec · DirectorArjun Balar · NEW YORK, NYDirectorSamuel Bakhoum · NEW YORK, NYDirectorEllie Mcguire · Cambridge, MADirectorLuc Dochez · Leiden, P7DirectorDavid Nicholson · Culver City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗